Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.499ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.499NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
N.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
N.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.212ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.212ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.212ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.212NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.61ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.61NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
JN.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.86ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.86ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.86ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.86NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.41.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.41.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.41.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.41.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GS.4.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GS.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.4.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JF.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JF.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JF.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JF.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JG.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JG.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used